 |
|
|
 |
|
Cervical Cancer Vaccine Continues to Spark Debate
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 | 4 | 5 Strong negative reaction from some segments of the public to state mandates caused pharmaceutical giant Merck, which makes the vaccine, to pull back on lobbying efforts advocating mandated vaccination. Repeated calls to Merck for comment were not returned.
Wright is also concerned that mandating the vaccine will lead to mandates for other vaccines. "That's what happened with the hepatitis B vaccine," she said. "It kind of slipped through in the early 1990s. The public health community rammed that through."
Abramson agreed that vaccines for other cancers should not be mandated. Mandated vaccines should be limited to those diseases that are highly contagious and spread by casual contact, he said. "Right now, I am not willing to cross that line," he said.
Text Continues Below

More information
For more information on cervical cancer, visit the American Cancer Society.
Page: << Prev | 1 | 2 | 3 | 4 | 5
|
Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 3/29/2007
|
 |

SOURCES: Robert Frenck, M.D., professor, pediatrics, Cincinnati Children's Hospital, member, American Academy of Pediatrics Committee on Infectious Diseases; Ralph Anderson, M.D., chairman, obstetrics and gynecology, University of North Texas Health Center, Denton; Jon Abramson, M.D., professor, infectious diseases, Wake Forest University Medical School, Winston-Salem, N.C., and chairman, U.S. Centers for Disease Control and Prevention, Advisory Committee on Immunization Practice; Wendy Wright, president, Concerned Women for America, Washington, D.C.
|